Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index C

C-reactive protein: Sec. 3, Ch. 42
in coronary artery disease: Sec. 3, Ch. 45
Cachexia: Sec. 2, Ch. 16
in cancer: Sec. 3, Ch. 50
CAD: (see Coronary artery disease)
Caffeine
osteoporosis and: Sec. 3, Ch. 22
urinary incontinence and: Sec. 3, Ch. 57
Calcification
of heart valves: Sec. 3, Ch. 48Sec. 3, Ch. 48
Calcitonin
for high calcium levels: Sec. 3, Ch. 18
in osteoporosis: Sec. 3, Ch. 22; Sec. 3, Ch. 22
Calcium channel blockers
in abnormal heart rhythms: Sec. 3, Ch. 47
in aortic regurgitation: Sec. 3, Ch. 48
in coronary artery disease: Sec. 3, Ch. 45
gum growth with: Sec. 3, Ch. 39
after heart attack: Sec. 3, Ch. 45
in heart valve disorders: Sec. 3, Ch. 48
in high blood pressure: Sec. 3, Ch. 43; Sec. 3, Ch. 43
urinary incontinence with: Sec. 3, Ch. 57
Calcium citrate: Sec. 3, Ch. 58
Calcium polycarbophil: Sec. 3, Ch. 55
Calcium pyrophosphate dihydrate crystal deposition disease: Sec. 3, Ch. 41
Calcium
in atherosclerosis: Sec. 3, Ch. 44
in bones: Sec. 1, Ch. 2
in coronary artery disease: Sec. 3, Ch. 45
deficiency of: Sec. 3, Ch. 17
dietary: Sec. 2, Ch. 5
heart valve accumulation of: Sec. 3, Ch. 48; Sec. 3, Ch. 48
high levels of (hypercalcemia): Sec. 3, Ch. 18
     in multiple myeloma: Sec. 3, Ch. 51; Sec. 3, Ch. 51
in joints: Sec. 3, Ch. 41
low levels of (hypocalcemia): Sec. 3, Ch. 18
supplemental
     for osteoporosis prevention: Sec. 3, Ch. 22
Calculi: (see Stones)
Calluses: Sec. 3, Ch. 40
Calorie requirements: Sec. 2, Ch. 5
Cancer: Sec. 3, Ch. 50
adjuvant therapy in: Sec. 3, Ch. 50
anemia with: Sec. 3, Ch. 49
biopsy in: Sec. 3, Ch. 50
blood clots with: Sec. 3, Ch. 49
brain
     dementia with: Sec. 3 Ch. 27 [sidebar]
breast: (see also Breasts, cancer of)
cervical
     screening for: Sec. 2, Ch. 4
colorectal: (see also colorectal cancer)
cure of: Sec. 3, Ch. 50; Sec. 3, Ch. 50
depression with: Sec. 3, Ch. 50
development of: Sec. 3, Ch. 50; Sec. 3, Ch. 50
diagnosis of: Sec. 3, Ch. 50
esophagus: Sec. 3, Ch. 54; Sec. 3, Ch. 54
garlic and: Sec. 2, Ch. 7
head: Sec. 3, Ch. 51
high calcium level in: Sec. 3, Ch. 18
hormone-like secretions of: Sec. 3, Ch. 50
hospice care for: Sec. 2, Ch. 9
immune system slowdown and: Sec. 1, Ch. 2
information resources on: 883-884
larynx: Sec. 3, Ch. 38
living with: Sec. 3, Ch. 50
lung: Sec. 3, Ch. 51
metastatic: Sec. 3, Ch. 51
mouth: Sec. 3, Ch. 39; Sec. 3, Ch. 51
neck: Sec. 3, Ch. 51
parathyroid hormone excess in: Sec. 3, Ch. 18
prostate: Sec. 3, Ch. 51 (see also Prostate gland, cancer of)
questions about: Sec. 3 Ch. 50 [sidebar]
refusal of treatment in: Sec. 3, Ch. 50
remission of: Sec. 3, Ch. 50
screening for: (see Screening tests, for cancer)
skin: Sec. 3, Ch. 51; Sec. 3 Ch. 35 [sidebar]
staging of: Sec. 3, Ch. 50
survival rate for: Sec. 3, Ch. 50
telomeres in: Sec. 1, Ch. 1
terms for: Sec. 3, Ch. 50
thyroid: Sec. 3, Ch. 33; Sec. 3, Ch. 33
treatment guidelines for: Sec. 3, Ch. 50
ubiquinone in: Sec. 2, Ch. 7
undernutrition and: Sec. 3 Ch. 17 [detail]
vulva: Sec. 3, Ch. 51
warning signs of: Sec. 3, Ch. 50
Candesartan
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Candidiasis
oral (thrush): Sec. 3, Ch. 39
Cane: Sec. 2, Ch. 13
after stroke: Sec. 2, Ch. 13
Canker sores: Sec. 3, Ch. 39
Capacity: Sec. 4, Ch. 65
Capillaries: Sec. 3, Ch. 44
Capsaicin
in osteoarthritis: Sec. 3, Ch. 41
in phingles: Sec. 3, Ch. 29
Captopril
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
urinary incontinence with: Sec. 3, Ch. 57
Cars: (see Automobiles; Driving)
Carbidopa: Sec. 3, Ch. 30
Carbohydrates: Sec. 2, Ch. 5
Carbon monoxide detector
Carbon monoxide
atherosclerosis and: Sec. 3, Ch. 44
Carbonic anhydrase inhibitors: Sec. 3, Ch. 36
Carcinoembryonic antigen (CEA): Sec. 3, Ch. 51
Carcinogens: Sec. 3, Ch. 50
Carcinoma-in-situ: Sec. 3, Ch. 50
Carcinoma: (see also Cancer)
Cardiac catheterization: Sec. 2, Ch. 10; Sec. 2, Ch. 10
in coronary artery disease: Sec. 3, Ch. 45
in heart attack: Sec. 3, Ch. 45
Cardiac glycosides: Sec. 3, Ch. 46
Cardiac rehabilitation: Sec. 2, Ch. 13; Sec. 3, Ch. 45
Cardiologist: Sec. 2, Ch. 9
Cardiomyopathy
dizziness with: Sec. 3, Ch. 20
Cardiopulmonary resuscitation (CPR)
in advance directive: Sec. 4, Ch. 65
in hypothermia: Sec. 3, Ch. 19
in ventricular fibrillation
Cardioversion: Sec. 3, Ch. 47
in atrial flutter: Sec. 3, Ch. 47
in ventricular tachycardia: Sec. 3, Ch. 47
Cardioverter-defibrillator: Sec. 3, Ch. 47
in atrial flutter and fibrillation
implanted
     in abnormal heart rhythms: Sec. 3, Ch. 47
     in heart failure: Sec. 3, Ch. 46
     in ventricular tachycardia: Sec. 3, Ch. 47
Care manager: Sec. 2, Ch. 9
Caregiver: Sec. 2, Ch. 15
burnout of: Sec. 2, Ch. 15; Sec. 2, Ch. 15; Sec. 2 Ch. 14 [sidebar]
challenges to: Sec. 2, Ch. 15
help for: Sec. 2, Ch. 15; Sec. 2, Ch. 15
Caregiving: Sec. 2, Ch. 5
cost of: Sec. 2, Ch. 15
long-distance: Sec. 2, Ch. 15
nutrition and: Sec. 3 Ch. 17 [detail]
rewards of: Sec. 2, Ch. 15
Caries
dental: Sec. 3, Ch. 39
Carisoprodol: Sec. 2, Ch. 6
medicinal herb interactions with
Carnitine
supplemental: Sec. 2, Ch. 7
Carotid artery: Sec. 3, Ch. 44
angiography of: Sec. 3, Ch. 28; Sec. 3, Ch. 28
blockage of: Sec. 3 Ch. 28 [detail]; Sec. 3, Ch. 28
     removal of: Sec. 3, Ch. 28; Sec. 3, Ch. 36
massage of: Sec. 3, Ch. 47
Carotid sinus syndrome: Sec. 3, Ch. 20; Sec. 3, Ch. 20
Carotid sinus
pressure testing of: Sec. 3, Ch. 20
carpal tunnel syndrome of: Sec. 3, Ch. 29
Carpal tunnel syndrome
in diabetes mellitus: Sec. 3, Ch. 34
Carteolol
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
Cartilage
aging of: Sec. 1, Ch. 2
osteoarthritis of: Sec. 3, Ch. 41
Carvedilol
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Cascara: Sec. 3, Ch. 55; Sec. 3, Ch. 55
Cast
for fracture: Sec. 3, Ch. 23
Castor oil: Sec. 3, Ch. 55
CAT scan: (see Computed tomography)
Cataracts: Sec. 3, Ch. 36
dizziness and: Sec. 3, Ch. 20
Catechol O-methyltransferase (COMT) inhibitors: Sec. 3, Ch. 30
Catheter ablation
in abnormal heart rhythms: Sec. 3, Ch. 47; Sec. 3, Ch. 47
Catheter(ization)
cardiac: Sec. 2, Ch. 10
     in coronary artery disease: Sec. 3, Ch. 45
     in heart attack: Sec. 3, Ch. 45
urinary: Sec. 2, Ch. 7
     in benign prostatic hyperplasia: Sec. 3, Ch. 59
     in incontinence: Sec. 3, Ch. 57; Sec. 3, Ch. 57
     infection and: Sec. 3, Ch. 56
     after surgery: Sec. 2, Ch. 12
Cavities (tooth decay): Sec. 3, Ch. 39
CEA (carcinoembryonic antigen): Sec. 3, Ch. 51
Cells
aging of: Sec. 1, Ch. 1
programmed death of: Sec. 1, Ch. 1
telomeres of: Sec. 1, Ch. 1
Cellulitis
with pressure sores: Sec. 3, Ch. 35
with venous ulcers: Sec. 3, Ch. 35
Central retinal artery
blockage of: Sec. 3, Ch. 36
Cerebellum: Sec. 3, Ch. 30
Cerumen: Sec. 3, Ch. 37
Cervical spondylosis
dizziness in: Sec. 3, Ch. 20
Cervix
Cevimeline: Sec. 3, Ch. 39
Chair
transfer from: Sec. 2, Ch. 13
Chalazion: Sec. 3, Ch. 36
Chamomile: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7; Sec. 2, Ch. 7
Coping with change: Sec. 4, Ch. 61
Charcot's joint: Sec. 3, Ch. 29
Chemotherapy: Sec. 3, Ch. 50
in breast cancer: Sec. 3, Ch. 51
in chronic lymphocytic leukemia: Sec. 3, Ch. 51
in colorectal cancer: Sec. 3, Ch. 51
fatigue with: Sec. 3, Ch. 50
hair loss with: Sec. 3, Ch. 50
in head cancer: Sec. 3, Ch. 51
in lung cancer: Sec. 3, Ch. 51
in mouth cancer: Sec. 3, Ch. 51
in multiple myeloma: Sec. 3, Ch. 51
nausea and vomiting with: Sec. 2, Ch. 16
in neck cancer: Sec. 3, Ch. 51
in prostate cancer: Sec. 3, Ch. 51
ubiquinone with: Sec. 2, Ch. 7
undernutrition and: Sec. 3 Ch. 17 [detail]
in vulvar cancer: Sec. 3, Ch. 51
weight loss with: Sec. 3, Ch. 50
Cherry angioma: Sec. 3 Ch. 35 [sidebar]
Chest x-ray
in COPD: Sec. 3, Ch. 53
in heart failure: Sec. 3, Ch. 46
in pneumonia: Sec. 3, Ch. 52
Chest pain
in acid reflux: Sec. 3, Ch. 54
in angina: Sec. 3, Ch. 44; Sec. 3, Ch. 45; Sec. 3, Ch. 45; Sec. 3, Ch. 45
in COPD
in heart valve disorders: Sec. 3, Ch. 48
in swallowing difficulty: Sec. 3, Ch. 54
Chickenpox: Sec. 3, Ch. 35 (see also Shingles [herpes zoster])
Children
caring for: Sec. 4, Ch. 63
Chiropractic
for pain: Sec. 3, Ch. 24
in rehabilitation: Sec. 2, Ch. 13
Chlamydia infection: Sec. 4, Ch. 63
Chlordiazepoxide: Sec. 2, Ch. 6; Sec. 2, Ch. 6
Chlorothiazide: Sec. 3, Ch. 43
Chlorpheniramine: Sec. 2, Ch. 6
urinary incontinence with: Sec. 3, Ch. 57
Chlorpromazine: Sec. 3, Ch. 32; Sec. 2, Ch. 6
medicinal herb interactions with
Chlorpropamide: Sec. 3, Ch. 34; Sec. 2, Ch. 6
medicinal herb interactions with: Sec. 2, Ch. 7
Chlorthalidone: Sec. 3, Ch. 18
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Chlorzoxazone: Sec. 2, Ch. 6
Cholesterol-lowering drugs: Sec. 3, Ch. 44; Sec. 3, Ch. 44
in coronary artery disease: Sec. 3, Ch. 45
Cholesterol
in atherosclerosis: Sec. 3, Ch. 44; Sec. 3, Ch. 44
in coronary artery disease: Sec. 3, Ch. 45
desirable level of: Sec. 3, Ch. 44
diet and: Sec. 3, Ch. 44
disease-related abnormalities in: Sec. 3, Ch. 44
garlic and: Sec. 2, Ch. 7
measurement of: Sec. 3, Ch. 17
stroke and: Sec. 3 Ch. 28 [detail]
Cholestyramine: Sec. 3, Ch. 44
undernutrition and: Sec. 3 Ch. 17 [detail]
Cholinesterase inhibitors: Sec. 3, Ch. 27
Chondroitin: Sec. 2, Ch. 7
in osteoarthritis: Sec. 3, Ch. 41
Chronic disease: Sec. 1, Ch. 3
anemia of: Sec. 3, Ch. 49; Sec. 3, Ch. 49
palliative and end-of-life care for: Sec. 2, Ch. 16
Chronic lymphocytic leukemia (CLL): Sec. 3, Ch. 51
Chronic obstructive pulmonary disease (COPD): Sec. 3, Ch. 53
cancer treatment and: Sec. 3, Ch. 50
dizziness with: Sec. 3, Ch. 20
exercise in: Sec. 3, Ch. 60
undernutrition and: Sec. 3 Ch. 17 [detail]
Chronic venous insufficiency: Sec. 3, Ch. 35; Sec. 3, Ch. 44; Sec. 3, Ch. 44; Sec. 3, Ch. 49
Chronologic age: Sec. 1, Ch. 1
Cigarette smoking
acid reflux and: Sec. 3, Ch. 54
arrhythmias with: Sec. 3, Ch. 47
atherosclerosis and: Sec. 3, Ch. 44
COPD and: Sec. 3, Ch. 53
coronary artery disease and: Sec. 3, Ch. 45
lung cancer and: Sec. 3, Ch. 51
mouth cancer and: Sec. 3, Ch. 51
quitting (cessation) of
     in stroke prevention: Sec. 3, Ch. 28
     in atherosclerosis: Sec. 3, Ch. 44
     in COPD: Sec. 3, Ch. 53
     in coronary artery disease: Sec. 3, Ch. 45
     in gastroesophageal reflux: Sec. 3, Ch. 54
undernutrition and: Sec. 3 Ch. 17 [detail]
Cimetidine: Sec. 2, Ch. 6
Circadian rhythm disorders: Sec. 3, Ch. 31
Circulation
blood: Sec. 3, Ch. 44
     to brain: Sec. 3, Ch. 20
     collateral: Sec. 3, Ch. 44
     to eye: Sec. 3, Ch. 36
     garlic and: Sec. 2, Ch. 7
     ginkgo biloba and: Sec. 2, Ch. 7; Sec. 2, Ch. 7
     in skin: Sec. 1, Ch. 2
coronary: Sec. 3, Ch. 45; Sec. 3, Ch. 46
Cisplatin
undernutrition and: Sec. 3 Ch. 17 [detail]
Citalopram: Sec. 3, Ch. 32
CK-MB
in heart attack: Sec. 3, Ch. 45
Claudication
in diabetes: Sec. 3, Ch. 34
in peripheral arterial disease: Sec. 3, Ch. 44; Sec. 3, Ch. 44; Sec. 3, Ch. 44; Sec. 3, Ch. 60
Claustrophobia
during CT scan: Sec. 2, Ch. 10
during MRI: Sec. 2, Ch. 10
Clavicle
fracture of: Sec. 3, Ch. 23
Clidinium: Sec. 2, Ch. 6
Clinical trial
for cancer treatment: Sec. 3, Ch. 50
CLL (chronic lymphocytic leukemia): Sec. 3, Ch. 51
Clopidogrel: Sec. 3 Ch. 49 [sidebar]; Sec. 3, Ch. 49
in coronary artery disease: Sec. 3, Ch. 45
in peripheral arterial disease: Sec. 3, Ch. 44
Clostridium difficile infection: Sec. 3, Ch. 55
Clothing
for hot weather: Sec. 3, Ch. 19
Clotting factors: Sec. 3, Ch. 49
disorders of: Sec. 3, Ch. 49; Sec. 3, Ch. 49
Clotting: Sec. 3, Ch. 49
disorders of: Sec. 3, Ch. 49 (see also Blood clots)
Clozapine: Sec. 3, Ch. 32
Cobalamin: (see Vitamin B12 [cobalamin])
Cochlea: Sec. 3, Ch. 37; Sec. 3, Ch. 37
Cochlear implant: Sec. 3, Ch. 37
Codeine
in diarrhea: Sec. 3, Ch. 55
Coenzyme Q: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7
Coffee
acid reflux and: Sec. 3, Ch. 54
urinary incontinence and: Sec. 3, Ch. 57
Cognitive impairment
age-related: Sec. 3 Ch. 27 [sidebar]
in dementia: (see Dementia)
mild: Sec. 3 Ch. 27 [sidebar]
stroke and: Sec. 3, Ch. 28
after stroke: Sec. 2, Ch. 13
temporary: (see Delirium)
Cognitive therapy
in pain management: Sec. 3, Ch. 24
Cola
urinary incontinence with: Sec. 3, Ch. 57
Colchicine
in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41
in pseudogout: Sec. 3, Ch. 41
Cold therapy (cryotherapy): Sec. 2, Ch. 13; Sec. 3, Ch. 24
for fracture: Sec. 3, Ch. 23
in osteoarthritis: Sec. 3, Ch. 41
in rheumatoid arthritis: Sec. 3, Ch. 41
Cold
common
     echinacea effects on: Sec. 2, Ch. 7
     laryngitis with: Sec. 3, Ch. 38
     rhinitis with: Sec. 3, Ch. 38
     sinusitis with: Sec. 3, Ch. 38
Colectomy: Sec. 3, Ch. 51
Colesevelam: Sec. 3, Ch. 44
Colestipol: Sec. 3, Ch. 44
Collagen
injection of
     in stress incontinence: Sec. 3, Ch. 57
Collarbone
fracture of: Sec. 3, Ch. 23
Collateral circulation: Sec. 3, Ch. 44
Colles' fracture: Sec. 3, Ch. 23
Colon: (see also Large intestine)
perforation of: Sec. 2, Ch. 10
Colonoscopy: Sec. 2, Ch. 10; Sec. 2, Ch. 10; Sec. 2, Ch. 10; Sec. 3, Ch. 51
in anemia: Sec. 3, Ch. 49
in constipation: Sec. 3, Ch. 55
Color
perception of: Sec. 1, Ch. 2
of sclera: Sec. 1, Ch. 2
Colorectal cancer
recurrence of: Sec. 3, Ch. 51
screening for: Sec. 2, Ch. 10; Sec. 3, Ch. 50
staging of: Sec. 3, Ch. 51
Colostomy: Sec. 3, Ch. 51
Coma
nonketotic hyperosmolar (hyperglycemic): Sec. 3, Ch. 34
myxedema: Sec. 3, Ch. 33
with stroke: Sec. 3, Ch. 28
Common cold: (see Cold, common)
Communication
with health care practitioners: Sec. 2, Ch. 8; Sec. 2, Ch. 9; Sec. 2, Ch. 10
translator for: Sec. 2, Ch. 11
Community involvement: Sec. 4, Ch. 61
information resources on: 889
Community services: Sec. 2, Ch. 9; Sec. 2, Ch. 15
Companionship: Sec. 4, Ch. 63
Compartment syndrome: Sec. 3, Ch. 23; Sec. 3, Ch. 23
Competency: Sec. 4, Ch. 65
Complementary medicine: Sec. 2, Ch. 7
Computed tomography: Sec. 2, Ch. 10
in aortic aneurysm: Sec. 3, Ch. 44
in aortic dissection: Sec. 3, Ch. 44
in coronary artery disease: Sec. 3, Ch. 45
in fracture: Sec. 3, Ch. 23
in lung cancer: Sec. 3, Ch. 51
in osteoporosis: Sec. 3, Ch. 22
in prostate cancer: Sec. 3, Ch. 51
in stroke: Sec. 3, Ch. 28
Computers
for home care: Sec. 2, Ch. 15
COMT (catechol O-methyltransferase) inhibitors: Sec. 3, Ch. 30
Confidentiality: Sec. 4, Ch. 65
Conformal radiotherapy
in prostate cancer: Sec. 3, Ch. 51
Confusion: Sec. 3, Ch. 25 (see also Delirium; Dementia)
capacity and: Sec. 4, Ch. 65
with hospitalization: Sec. 2, Ch. 11
after surgery: Sec. 2, Ch. 12
at end of life: Sec. 2, Ch. 16
Congestive heart failure: (see Heart failure)
Consciousness
loss of
     in ventricular fibrillation: Sec. 3, Ch. 47
Consent
informed: Sec. 4, Ch. 65
Constipation: Sec. 3, Ch. 55
opioid-related: Sec. 3, Ch. 50
in terminal illness: Sec. 2, Ch. 16
Constriction devices
in erectile dysfunction: Sec. 3, Ch. 59
Consultant pharmacist: Sec. 2, Ch. 9
Continuing care retirement community (life-care community): Sec. 2, Ch. 9; Sec. 2, Ch. 14; Sec. 2, Ch. 14
Continuing education: Sec. 4, Ch. 61, 884
Continuous positive airway pressure (CPAP): Sec. 3, Ch. 31
Contracture
after fracture treatment: Sec. 3, Ch. 23
Cooling therapy
in heat stroke: Sec. 3, Ch. 19
Cooperatives
for adult day care: Sec. 2, Ch. 15
Coordination exercise: Sec. 2, Ch. 13
COPD (chronic obstructive pulmonary disease): Sec. 3, Ch. 53
cancer treatment and: Sec. 3, Ch. 50
dizziness with: Sec. 3, Ch. 20
exercise in: Sec. 3, Ch. 60
undernutrition and: Sec. 3 Ch. 17 [detail]
Corns: Sec. 3, Ch. 40
Coronary arteries
atherosclerosis of: (see Coronary artery disease) Sec. 3, Ch. 45
spasm of: Sec. 3, Ch. 45
Coronary artery bypass graft surgery: Sec. 3, Ch. 45; Sec. 3 Ch. 48 [sidebar]
Coronary artery disease: Sec. 3, Ch. 44; Sec. 3, Ch. 45
angiography in: Sec. 2, Ch. 10; Sec. 2, Ch. 10
exercise in: Sec. 3, Ch. 60
information resources on: 884
long-term outlook for: Sec. 3, Ch. 45
prevention of: Sec. 3, Ch. 45
rehabilitation for: Sec. 2, Ch. 13; Sec. 3, Ch. 60
risk factors for: Sec. 3, Ch. 45; Sec. 3, Ch. 45
treatment of: Sec. 3, Ch. 45
Coronary care unit: Sec. 2, Ch. 11
Corticosteroids
in COPD: Sec. 3, Ch. 53
in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41
in idiopathic thrombocytopenic purpura: Sec. 3, Ch. 49
in osteoarthritis: Sec. 3, Ch. 41
medicinal herb interactions with: Sec. 2, Ch. 7
in multiple myeloma: Sec. 3, Ch. 51
in myelofibrosis: Sec. 3, Ch. 49
in polymyalgia rheumatic: Sec. 3, Ch. 42
in rheumatoid arthritis: Sec. 3, Ch. 41; Sec. 3, Ch. 41
in temporal arteritis: Sec. 3, Ch. 42
weight gain with: Sec. 3, Ch. 17
Cough
aging-related changes in: Sec. 1, Ch. 2
as defense mechanism: Sec. 3, Ch. 52
bed rest effects on: Sec. 2, Ch. 11
in chronic bronchitis: Sec. 3, Ch. 53
in COPD: Sec. 3, Ch. 53
in heart failure: Sec. 3, Ch. 46
in influenza: Sec. 3, Ch. 52
in pneumonia: Sec. 3, Ch. 52
in terminal illness: Sec. 2, Ch. 16
urinary incontinence with: Sec. 3, Ch. 57
Counseling
in anxiety: Sec. 3, Ch. 32
after death of loved one: Sec. 4, Ch. 61
in depression: Sec. 3, Ch. 32
COX-2 inhibitors (coxibs)
in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41
in osteoarthritis: Sec. 3, Ch. 41
in pseudogout: Sec. 3, Ch. 41
in rheumatoid arthritis: Sec. 3, Ch. 41
COX-II inhibitors (coxibs): Sec. 3, Ch. 24
CPAP (continuous positive airway pressure): Sec. 3, Ch. 31
CPR (cardiopulmonary resuscitation)
in advance directive: Sec. 4, Ch. 65
in hypothermia: Sec. 3, Ch. 19
Cramp(s)
in atherosclerosis: Sec. 3, Ch. 44
heat: Sec. 3, Ch. 19; Sec. 3, Ch. 19
leg: Sec. 3, Ch. 31
writer's: Sec. 3, Ch. 30
Crashes (automobile): Sec. 4, Ch. 62
Creams
for dry skin: Sec. 3, Ch. 35
Creatine: Sec. 2, Ch. 7
Crepitus: Sec. 3, Ch. 41
Creutzfeldt-Jakob disease: Sec. 3 Ch. 27 [sidebar]
Crowns
dental: Sec. 3, Ch. 39
Crutches: Sec. 2, Ch. 13
Cryotherapy: Sec. 2, Ch. 13
for fracture: Sec. 3, Ch. 23
in osteoarthritis: Sec. 3, Ch. 41
for pain: Sec. 3, Ch. 24
in rheumatoid arthritis: Sec. 3, Ch. 41
Crystal deposition
in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41
in pseudogout: Sec. 3, Ch. 41
CSF: (see Cerebrospinal fluid)
CT: (see Computed tomography)
Culture
sputum: Sec. 3, Ch. 52
urine: Sec. 3, Ch. 56
Cyanosis
in heart failure: Sec. 3, Ch. 46
Cyclobenzaprine: Sec. 2, Ch. 6
Cyclophosphamide: Sec. 3, Ch. 41
Cyclosporine
medicinal herb interactions with: Sec. 2, Ch. 7
in rheumatoid arthritis: Sec. 3, Ch. 41
Cyproheptadine: Sec. 2, Ch. 6
Cyst(s)
in breast: Sec. 3, Ch. 51
Cystitis: Sec. 3, Ch. 56
Cystocele: Sec. 3, Ch. 56; Sec. 3, Ch. 58; Sec. 3, Ch. 58
urinary incontinence and: Sec. 3, Ch. 57
Cystoscopy
infection with: Sec. 3, Ch. 56
Cytokines
in cancer: Sec. 3, Ch. 50
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.